Conversely, the β2-AR antagonists can delay the tumor growth or eventually attenuate its metastatic potential, for example, suppressing the secretion of the matrix metalloproteinase (MMPs) in several tumors, affecting their invasive potential [40]. The gene discussed is ADRB2; the disease is neoplasm.